Compatibility analysis of bergapten with different pharmaceutical excipients used in nanostructured lipid carriers

被引:4
作者
Arshad, Shumaila [1 ,2 ]
Masood-ur-Rehman [2 ]
Zulfiqar, Juwairiya [3 ]
Najam, Saima [1 ]
Asim, Hussain Mulazim [4 ]
Abid, Farah [1 ,5 ]
机构
[1] Univ Lahore, Fac Pharm, Lahore, Pakistan
[2] Riphah Int Univ, Riphah Inst Pharmaceut Sci, Islamabad, Pakistan
[3] Univ Westminster, Sch Life Sci, London, England
[4] Univ Sargodha, Fac Pharm, Dept Pharmaceut, Sargodha, Pakistan
[5] Govt Coll Univ Faisalabad, Fac Pharmaceut Sci, Dept Pharmacol, Faisalabad, Pakistan
关键词
Fourier-transform infrared spectroscopy (FTIR); bergapten; physical mixture; nanostructured lipid carriers (nlcs); compatibility; CNIDIUM-MONNIERI; NANOPARTICLES; FTIR; COUMARINS;
D O I
10.36721/PJPS.2019.32.6.SUP.2879-2885.1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In pharmaceuticals sciences, Fourier-transform infrared spectroscopy (FTIR) is a very useful technique to measure the compatibility and interaction between ingredients, therefore in the current study, compatibility of bergapten with different excipients was analyzed via FTIR. Nanostructured lipid carriers (NLCs) are the second generation of lipid nanocarriers and very useful for the drug delivery systems. Nanoparticles (NPs) were prepared by a nanotemplate engineering technique and scanning of pure drug, individual ingredients and, physical mixtures of different ingredients was carried out. The characteristic peak of the carboxylic groups of bergapten is shifted from 3088.1 cm(-1) to 3399.3 cm(-1) due to formulation development and it confirmed that it was properly incorporated into the formulation. Other peaks of the drug were also present in formulation with minor shortening/broadening of peaks. The resulted peaks of IR spectra depicted that the ingredients used in the formulation had no considerable interaction and were found compatible with each other.
引用
收藏
页码:2879 / 2885
页数:7
相关论文
共 27 条
[1]  
Ahuja S., 2010, Handbook of modern pharmaceutical analysis, V10
[2]   GENOTOXICITY OF BERGAPTEN AND BERGAMOT OIL IN SACCHAROMYCES-CEREVISIAE [J].
AVERBECK, D ;
AVERBECK, S ;
DUBERTRET, L ;
YOUNG, AR ;
MORLIERE, P .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1990, 7 (2-4) :209-229
[3]   Span-60-based organogels as probable matrices for transdermal/topical delivery systems [J].
Behera, B. ;
Patil, V. ;
Sagiri, S. S. ;
Pal, K. ;
Ray, S. S. .
JOURNAL OF APPLIED POLYMER SCIENCE, 2012, 125 (02) :852-863
[4]   Effect of bergapten from Heracleum nepalense root on production of proinflammatory cytokines [J].
Bose, Sekhar K. ;
Dewanjee, Saikat ;
Sahu, Ranabir ;
Dey, Sankar P. .
NATURAL PRODUCT RESEARCH, 2011, 25 (15) :1444-1449
[5]   Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest [J].
Bruni, Renato ;
Barreca, Davide ;
Protti, Michele ;
Brighenti, Virginia ;
Righetti, Laura ;
Anceschi, Lisa ;
Mercolini, Laura ;
Benvenuti, Stefania ;
Gattuso, Giuseppe ;
Pellati, Federica .
MOLECULES, 2019, 24 (11)
[6]   Preparation of microcapsules by complex coacervation of gum Arabic and chitosan [J].
Butstraen, Chloe ;
Salauen, Fabien .
CARBOHYDRATE POLYMERS, 2014, 99 :608-616
[7]   ANTIINFLAMMATORY AND ANALGESIC ACTIVITIES FROM ROOTS OF ANGELICA-PUBESCENS [J].
CHEN, YF ;
TSAI, HY ;
WU, TS .
PLANTA MEDICA, 1995, 61 (01) :2-8
[8]   Breast Cancer Statistics, 2013 [J].
DeSantis, Carol ;
Ma, Jiemin ;
Bryan, Leah ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (01) :52-62
[9]  
EHRSSON H, 1994, EUR J CLIN PHARMACOL, V46, P375
[10]   Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC) [J].
Fang, Jia-You ;
Fang, Chia-Lang ;
Liu, Chi-Hsien ;
Su, Yu-Han .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 70 (02) :633-640